Login / Signup

Prognostic significance of MATR3 in stage I and II non-small cell lung cancer patients.

Justyna DurślewiczAnna Klimaszewska-WiśniewskaJakub JóźwickiPaulina AntosikKamil KozerawskiDariusz GrzankaMarcin Braun
Published in: Journal of cancer research and clinical oncology (2022)
In conclusion, the present study warrants further investigation into the biological and prognostic value of MATR3 as a potential prognostic marker in early-stage NSCLC patients.
Keyphrases